Cannika Holdings

Cannika is a biotechnology company specializing in the research, development, and production of pharmaceutical-grade cannabinoid-based medicines. Headquartered in South Africa with research operations in the United Kingdom, the company focuses on bridging the gap between botanical extracts and standardized pharmaceutical products. Cannika's leadership includes industry veterans from GW Pharmaceuticals, bringing significant expertise in the cultivation and clinical application of cannabinoids. The company operates state-of-the-art GACP and GMP-compliant facilities to produce high-quality medical cannabis for various therapeutic indications. Their primary areas of focus include chronic pain management, epilepsy, and inflammatory conditions. By leveraging advanced extraction and formulation technologies, Cannika aims to provide evidence-based, consistent treatments for patients with unmet medical needs.